📅 This week, Constellation Brands ($STZ), Biogen Inc. ($BIIB), Tilray Brands ($TLRY) and Tesco PLC ($TSCO) are leading the pack releasing their earnings earlier than the rest.
📌 We have prepared data on upcoming earnings reports from these companies. So, check out 👇
Tuesday, October 4th
- Biogen Inc $BIIB.OQ – is a biopharmaceutical company in the United States. The company is expected to release its Q3 earnings report on Tuesday, October 4, 2022. This will be an important indicator of the company’s financial health, as last quarter’s results were more than 20% higher than projected. We will soon find out if Biogen Inc. will be able to replicate this success and surpass the $2.59 billion in revenue that the company generated last quarter.
Wednesday, October 5th
- Tesco PLC $TSCO.L – is a British multinational corporation and the largest retail chain in Great Britain. The company is expected to release earnings figures for S1 as early as Wednesday, October 5, 2022. This is a very important report because in the last reporting period, the company managed to increase revenue, but net income decreased by more than 80%. If Tesco fails to recover net income and EPS, the stock price could fall significantly.
Thursday, October 6th
- Constellation Brands Inc $STZ.N – is a Fortune 500 company, is an American producer and marketer of beer, wine, and spirits. The company is expected to release earnings figures for Q2 as early as Thursday, October 6, 2022. According to Zacks Investment Research, based on 5 analysts’ forecasts, the consensus EPS forecast for the quarter is $2.83. The reported EPS for the same quarter last year was $2.38. Accordingly, the company stands a good chance of gaining new growth.
Friday, October 7th
- Tilray Brands Inc $TLRY.re – is a global cannabis and consumer products pharmaceutical company headquartered in the United States and headquartered in New York City. The company is expected to release earnings figures for Q1 as early as Friday, October 7, 2022. According to Zacks Investment Research, based on 5 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.06. The reported EPS for the same quarter last year was $-0.08. Accordingly, the company can improve its results, but it still has a lot of costs, which does not allow its shares to grow enough.
*Please note that dates and/or times of the release are subject to change.
